TSC22D1 is a newly identified inhibitor of insulin secretion in pancreatic beta cells

Sümbül Yıldırım1,2,3,4, Amit Mhamane3,4, Svenja Lösch1,3,4

  • 1Department of Endocrinology and Metabolism, Joint Heidelberg IDC Translational Diabetes Program, Heidelberg University Hospital, Heidelberg, Germany.

The FEBS Journal
|July 18, 2025
PubMed

Insights

Researchers discovered that the TSC22D1 protein regulates pancreatic beta cell function and insulin secretion. This finding offers new insights into potential treatments for diabetes mellitus.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Cell Biology

Background:

  • Pancreatic beta cell dysfunction causes high blood glucose levels, leading to diabetes mellitus, a major global health issue.
  • Identifying molecular regulators of beta cell function is crucial for developing novel antidiabetic therapies.

Purpose of the Study:

  • To identify novel regulators of pancreatic beta cell function.
  • To investigate the role of the transforming growth factor β-1 stimulated clone D1 (TSC22D1) protein in beta cell function and glucose homeostasis.

Main Methods:

  • Utilized INS-1E rat insulinoma cell line for experiments.
  • Performed gene expression analysis (RNA-Seq) and protein-protein interaction studies (interactome analysis).
  • Assessed glucose-stimulated insulin secretion and intracellular insulin content.

Main Results:

  • Depletion of TSC22D1 enhanced key beta cell identity genes (Ins1, Ins2, Pdx1, Slc2a2, Nkx6.1) and promoted glucose-stimulated insulin secretion.
  • Demonstrated a reciprocal interaction and regulation between TSC22D1 and Forkhead box protein O1 (FoxO1).
  • Identified TSC22D1's critical role in glucose-responsive processes like mRNA processing, ribonucleoprotein complex biogenesis, and Golgi vesicle transport.

Conclusions:

  • TSC22D1 is a novel, evolutionarily conserved regulator of pancreatic beta cell function.
  • TSC22D1 influences beta cell function at multiple molecular and cellular levels.
  • Targeting TSC22D1 may offer therapeutic potential for metabolic diseases, including diabetes mellitus.

Related Concept Videos

Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
5.4K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.4K
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
262
Insulin: The Receptor and Signaling Pathways01:28

Insulin: The Receptor and Signaling Pathways

Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
1.5K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
560
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.9K